Market Value1,213,998,640
Total Holdings41
File Date2023-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
BPMC / Blueprint Medicines Corporation
TWST / Twist Bioscience Corporation
NVTA / Invitae Corporation
VERV / Verve Therapeutics, Inc.
GLUE / Monte Rosa Therapeutics, Inc.
NTLA / Intellia Therapeutics, Inc.
SRPT / Sarepta Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc. Call
FATE / Fate Therapeutics, Inc.
TSVT / 2seventy bio, Inc.
EXAS / Exact Sciences Corporation
RNA / Avidity Biosciences, Inc.
PRME / Prime Medicine, Inc.
SLGC / Standard BioTools Inc.
OMIC / Singular Genomics Systems, Inc.
DH / Definitive Healthcare Corp.
MRNA / Moderna, Inc.
MRNA / Moderna, Inc. Call
ARVN / Arvinas, Inc.
VEEV / Veeva Systems Inc.
WVE / Wave Life Sciences Ltd.
KROS / Keros Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
RXDX / Prometheus Biosciences Inc
EXAI / Exscientia plc - Depositary Receipt (Common Stock)
EQRX / EQRx Inc
DICE / DICE Therapeutics Inc
OPRX / OptimizeRx Corporation
SMFR / Sema4 Holdings Corp - Class A
KRON / Kronos Bio, Inc.
LIANY / LianBio - Depositary Receipt (Common Stock)
INCY / Incyte Corporation
RLAY / Relay Therapeutics, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
TNGX / Tango Therapeutics, Inc.
BEAM / Beam Therapeutics Inc.
MXCT / MaxCyte, Inc.
DNLI / Denali Therapeutics Inc.
PLRX / Pliant Therapeutics, Inc.
RVMD / Revolution Medicines, Inc.
SRPT / Sarepta Therapeutics, Inc. Call
FDMT / 4D Molecular Therapeutics, Inc.
ABCL / AbCellera Biologics Inc.
ABSI / Absci Corporation
TNYA / Tenaya Therapeutics, Inc.
BLFS / BioLife Solutions, Inc.
IPSC / Century Therapeutics, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
ILMN / Illumina, Inc.